Relative Enthalpy of Formation for Co-Crystals of Small Organic Molecules

被引:57
作者
Oliveira, Mark A. [1 ,3 ]
Peterson, Matthew L. [2 ]
Davey, Roger J. [3 ]
机构
[1] Transform Pharmaceut, Lexington, MA 01730 USA
[2] Amgen Inc, Cambridge, MA 02421 USA
[3] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M60 1QD, Lancs, England
关键词
PHARMACEUTICAL PHASES; CARBAMAZEPINE; POLYMORPHISM;
D O I
10.1021/cg101214m
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Enthalpy of formation values for 1:1 carbamazepine:saccharin (CBZ:SAC), cyheptamide:saccharin (CYH:SAC), and 10,11-dihydrocarbmazepine:saccharin (HCBZ:SAC) co-crystals and relative enthalpy differences between polymorphs of the co-crystal formers-CBZ(P2(1)/c, P (1) over bar), CYH (P2(1)/c, P (1) over bar), and HCBZ (P2(1)/c, Pbca)-were calculated from enthalpy of solution measurements. The results showed that the co-crystals were enthalpically stabilized and the more stable polymorphs of the co-formers were CBZ-P2(1)/c, CYH-P2(1)/c, and HCBZ-Pbca. The differences in enthalpies between polymorphs were related to the differences in the packing of the molecules. Likewise, the heats of formation of the co-crystals were related to differences in molecular and crystal structures. The transfer enthalpies for the components were assessed and included in the enthalpy of formation calculation. The free energy of formation of CBZ:SAC calculated from the ternary CBZ-SAC-methanol phase diagram showed that the co-crystal was the stable thermodynamic form, and the kinetics of crystallization followed the thermodynamics of crystallization.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 23 条
[1]
AakerOy C.B., 2003, COMPREHENSIVE COORDI, V1, P679
[2]
Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[3]
NIST and standards for calorimetry [J].
Archer, DG ;
Kirklin, DR .
THERMOCHIMICA ACTA, 2000, 347 (1-2) :21-30
[4]
X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE [J].
BANDOLI, G ;
NICOLINI, M ;
ONGARO, A ;
VOLPE, G ;
RUBELLO, A .
JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02) :177-183
[5]
Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules [J].
Cruz Cabeza, Aurora J. ;
Day, Graeme M. ;
Motherwell, W. D. Samuel ;
Jones, William .
CRYSTAL GROWTH & DESIGN, 2007, 7 (01) :100-107
[6]
[7]
Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine [J].
Fleischman, SG ;
Kuduva, SS ;
McMahon, JA ;
Moulton, B ;
Walsh, RDB ;
Rodríguez-Hornedo, N ;
Zaworotko, MJ .
CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :909-919
[8]
A catemer-to-dimer structural transformation in cyheptamide [J].
Florence, A. J. ;
Shankland, K. ;
Gelbrich, T. ;
Hursthouse, M. B. ;
Shankland, N. ;
Johnston, A. ;
Fernandes, P. ;
Leech, C. K. .
CRYSTENGCOMM, 2008, 10 (01) :26-28
[9]
Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I [J].
Grzesiak, AL ;
Lang, MD ;
Kim, K ;
Matzger, AJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (11) :2260-2271
[10]
2-Bromo-1-chlorophenyl-3-(4-methoxyphenyl)prop-2-en-1-one [J].
Harrison, WTA ;
Yathirajan, HS ;
Sarojini, BK ;
Narayana, B ;
Raj, KKV .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 :O1578-O1579